Prise en charge diagnostique et thérapeutique des infections à Aspergillus sp. chez le patient immunodéprimé. Recommandations du CHRU de lille - version 4 - novembre 2004

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Medecine Et Maladies Infectieuses

• Publication date

  2005-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.MEDMAL.2005.01.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination antifungal therapy for invasive aspergillosis.

  2005cited by this paper
• Diagnosing Invasive Aspergillosis during Antifungal Therapy by PCR Analysis of Blood Samples

  2004cited by this paper
• Invasive aspergillosis in patients with solid tumors

  2004cited by this paper
• Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

  2004cited by this paper
• Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction

  2004cited by this paper
• Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β-d-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders

  2004cited by this paper
• Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

  2004cited by this paper
• Liposomal Nystatin in Patients with Invasive Aspergillosis Refractory to or Intolerant of Amphotericin B

  2004cited by this paper
• Prospective clinical evaluation of a LightCyclerTM‐mediated polymerase chain reaction assay, a nested‐PCR assay and a galactomannan enzyme‐linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients

  2004cited by this paper
• Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

  2004cited by this paper
• False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

  2004cited by this paper
• False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

  2003cited by this paper
• Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

  2003cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.

  2002cited by this paper
• In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

  2002cited by this paper
• Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

  2002cited by this paper
• Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

  2002cited by this paper
• Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

  2002cited by this paper
• Combination therapy with caspofungin and amphotericin B lipid complex.

  2002cited by this paper
• Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

  2002cited by this paper
• A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.

  2002cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy

  2001cited by this paper
• Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.

  2001cited by this paper
• Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients.

  2001cited by this paper
• Prevention of fungal and hepatitis virus infections in liver transplantation.

  2001cited by this paper
• Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature.

  2001cited by this paper
• Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completion

  2001cited by this paper
• Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.

  2001cited by this paper
• Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients.

  2001cited by this paper
• Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.

  2001cited by this paper
• Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

  2001cited by this paper
• Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis.

  2001cited by this paper
• Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

  2001cited by this paper
• Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.

  2001cited by this paper
• Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia

  2001cited by this paper
• Aspergillosis case-fatality rate: systematic review of the literature.

  2001cited by this paper
• Practice Guidelines for Diseases Caused by Aspergillus

  2000cited by this paper
• Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.

  2000cited by this paper
• A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.

  2000cited by this paper
• Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

  2000cited by this paper
• Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients.

  2000cited by this paper
• Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment

  2000cited by this paper
• Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients

  2000cited by this paper
• Role of Antiretroviral Therapy in Long-Term Survival of Patients with AIDS-Related Pulmonary Aspergillosis

  2000cited by this paper
• Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.

  2000cited by this paper
• Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?

  2000cited by this paper
• Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

  2000cited by this paper
• Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.

  2000cited by this paper
• Fungal Infections in Patients With Neutropenia

  2000cited by this paper
• Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

  2000cited by this paper
• A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

  2000cited by this paper
• Invasive aspergillosis in transplant recipients.

  1999cited by this paper
• Five‐year‐survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long‐term survival

  1999cited by this paper
• Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group.

  1999cited by this paper
• Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.

  1999cited by this paper
• Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

  1999cited by this paper
• A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

  1999cited by this paper
• Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation.

  1999cited by this paper
• Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.

  1999cited by this paper
• Stratégies diagnostique et thérapeutique dans les aspergilloses pulmonaires invasives des patients atteints d’hémopathies malignes*

  1998cited by this paper
• Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

  1998cited by this paper
• An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

  1998cited by this paper
• Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.

  1998cited by this paper
• Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

  1998cited by this paper
• Changing role of invasive aspergillosis in AIDS--a case control study.

  1998cited by this paper
• Impact of previous aspergillosis on the outcome of bone marrow transplantation.

  1998cited by this paper
• Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis

  1997cited by this paper
• Surgical management of invasive pulmonary aspergillosis in neutropenic patients.

  1997cited by this paper
• Prospective cohort study of predictors of incident low back pain in nurses

  1997cited by this paper
• A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

  1997cited by this paper
• Aspergillosis in systemic lupus erythematosus.

  1996cited by this paper
• Therapeutic outcome in invasive aspergillosis.

  1996cited by this paper
• Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.

  1995cited by this paper
• Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B.

  1993cited by this paper
• The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.

  1991cited by this paper

• Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit

  2017cites this paper
• Antifungal stewardship: implementation in a French teaching hospital.

  2014cites this paper
• Analysis of antimicrobial consumption and cost in a teaching hospital.

  2014cites this paper
• Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients

  2014cites this paper
• Application of ATC/DDD methodology to eveluate of antibiotic use in a general hospital in Turkey

  2013cites this paper
• [Pulmonary aspergillosis and HIV infection: about two cases].

  2012cites this paper
• Aspergillose invasive en onco-hématologie pédiatrique

  2012cites this paper
• Aspergillose primitive de la fosse cérébrale postérieure chez un patient immunocompétent

  2011cites this paper
• [Primitive aspergillosis of the posterior cerebral fossa in immunocompetent patient].

  2011cites this paper
• Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco‐haematology

  2011cites this paper
• Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients

  2009cites this paper
• [Clinical audit on the use of expensive systemic antifungals in the Besançon University Hospital].

  2009cites this paper
• Les antifongiques systémiques Partie 2 : éléments thérapeutiques

  2008cites this paper
• Démarche diagnostique et prise en charge des infections fongiques chez les patients immunodéprimés

  2007cites this paper
• Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.

  2007cites this paper
• Zygomycose pulmonaire chez un patient traité pour une aspergillose invasive possible

  2006cites this paper
• [Acute invasive pulmonary aspergillosis in chronic lung disease--a review].

  2006cites this paper
• Aspergillose pulmonaire aiguë invasive et pathologies pulmonaires chroniques

  2006cites this paper